Testing Laboratories - Companies & Stock Screener

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

YoY Change

Thermo Fisher Scientific Inc.

TMO

Market Cap $331.91B

Dividends 0.3%

P/E Ratio 35.5

Revenue $12.1B +9.1%

Net Income $1.72B +6.5%

Profit Margin +14.2%

Employees 75K

View Stock

Thermo Fisher Scientific Inc.

0R0H.L

Market Cap $331.91B

Dividends 0.3%

P/E Ratio 35.5

Revenue $12.1B +9.1%

Net Income $1.72B +6.5%

Profit Margin +14.2%

Employees 75K

View Stock

Thermo Fisher Scientific Inc.

TMO.NE

Market Cap $331.91B

Dividends 0.3%

P/E Ratio 35.5

Revenue $12.1B +9.1%

Net Income $1.72B +6.5%

Profit Margin +14.2%

Employees 75K

View Stock

Thermo Fisher Scientific Inc.

TN8.DE

Market Cap $331.91B

Dividends 0.3%

P/E Ratio 35.5

Revenue $12.1B +9.1%

Net Income $1.72B +6.5%

Profit Margin +14.2%

Employees 75K

View Stock

Wuxi Biologics (Cayman) Inc. - ADR

WXXWY

Market Cap $188.53B

Dividends 0.0%

P/E Ratio 32.1

Revenue $11.7B +17.1%

Net Income $2.41B +3.1%

Profit Margin +20.7%

Employees 14.71K

View Stock

WuXi Biologics (Cayman) Inc.

2269.HK

Market Cap $188.53B

Dividends 0.0%

P/E Ratio 32.1

Revenue $11.7B +17.1%

Net Income $2.41B +3.1%

Profit Margin +20.7%

Employees 14.71K

View Stock

WuXi Biologics (Cayman) Inc.

WXIBF

Market Cap $188.53B

Dividends 0.0%

P/E Ratio 32.1

Revenue $11.7B +17.1%

Net Income $2.41B +3.1%

Profit Margin +20.7%

Employees 14.71K

View Stock

Agilent Technologies Inc.

Market Cap $48.8B

Dividends 0.6%

P/E Ratio 34.0

Revenue $1.88B +8.1%

Net Income $362M +7.7%

Profit Margin +19.3%

Employees 18.1K

View Stock

Agilent Technologies, Inc.

0HAV.L

Market Cap $48.8B

Dividends 0.6%

P/E Ratio 34.0

Revenue $1.88B +8.1%

Net Income $362M +7.7%

Profit Margin +19.3%

Employees 18.1K

View Stock

10x Genomics Inc - Ordinary Shares - Class A

TXG

Market Cap $9.32B

Dividends 0.0%

P/E Ratio -121.3

Revenue $151M -12.6%

Net Income -$17.9M -151.9%

Profit Margin -11.9%

View Stock

Stevanato Group Spa

STVN

Market Cap $5.32B

Dividends 0.3%

P/E Ratio 36.2

Revenue $302M +7.8%

Net Income $23M -22.6%

Profit Margin +7.6%

View Stock

Sotera Health Co

SHC

Market Cap $5.16B

Dividends 0.0%

P/E Ratio 31.6

Revenue $321M +9.2%

Net Income $53.6M +573.7%

Profit Margin +16.7%

Employees 3K

View Stock

Neogenomics Inc.

NEO

Market Cap $2.16B

Dividends 0.0%

P/E Ratio -41.8

Revenue $202M +11.2%

Net Income $2.24M -105.0%

Profit Margin +1.1%

Employees 1.6K

View Stock

Absci Corp

ABSI

Market Cap $1.58B

Dividends 0.0%

P/E Ratio -11.5

Revenue $318k -46.4%

Net Income -$33.2M +8.6%

Profit Margin -10443.4%

View Stock

Cytek BioSciences Inc

CTKB

Market Cap $726.6M

Dividends 0.0%

P/E Ratio -9.0

Revenue $48.1M +5.6%

Net Income -$12.2M +117.8%

Profit Margin -25.3%

Employees 2.02K

View Stock

Nautilus Biotechnology Inc

NAUT

Market Cap $412.31M

Dividends 0.0%

P/E Ratio -7.2

Revenue $190k

Net Income -$14.5M -3.8%

Profit Margin -7615.3%

View Stock

SomaLogic Inc - Units (1 Ord Share Class A & 1/5 War)

CMIIU

Market Cap $396.23M

Dividends 0.0%

P/E Ratio 205.4

Revenue $0.00

Net Income $366k

Profit Margin

View Stock

SomaLogic Inc - Class A

SLGC

Market Cap $396.23M

Dividends 0.0%

P/E Ratio -3.6

Revenue $0.00

Net Income $366k

Profit Margin

View Stock

Alpha Teknova Inc

TKNO

Market Cap $344.68M

Dividends 0.0%

P/E Ratio -20.4

Revenue $12.2M +18.5%

Net Income -$3.17M -11.2%

Profit Margin -26.0%

Employees 193

View Stock

Quantum-Si Incorporated - Ordinary Shares - Class A

QSI

Market Cap $278.52M

Dividends 0.0%

P/E Ratio -3.0

Revenue $344k -41.8%

Net Income -$23.5M -18.4%

Profit Margin -6841.3%

Employees 115

View Stock

Stock Screener

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

Wuxi Biologics (Cayman) Inc. - ADR

Wuxi Biologics (Cayman) Inc. - ADR

WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.

Agilent Technologies Inc.

Agilent Technologies Inc.

Agilent Technologies, Inc.

Agilent Technologies, Inc.

10x Genomics Inc - Ordinary Shares - Class A

10x Genomics Inc - Ordinary Shares - Class A

Stevanato Group Spa

Stevanato Group Spa

Sotera Health Co

Sotera Health Co

Neogenomics Inc.

Neogenomics Inc.

Absci Corp

Absci Corp

Cytek BioSciences Inc

Cytek BioSciences Inc

Nautilus Biotechnology Inc

Nautilus Biotechnology Inc

SomaLogic Inc - Units (1 Ord Share Class A & 1/5 War)

SomaLogic Inc - Units (1 Ord Share Class A & 1/5 War)

SomaLogic Inc - Class A

SomaLogic Inc - Class A

Alpha Teknova Inc

Alpha Teknova Inc

Quantum-Si Incorporated - Ordinary Shares - Class A

Quantum-Si Incorporated - Ordinary Shares - Class A

Cookie Settings